Sr, thank you for the response but my question is still unanswered because if the FDA clearance and labeling guidelines allow for the device to be marketed as more effective than NSAIDS then BIEL could demand even more money for said OEM and licensing deals. Do we know if the FDA has given us a green light to make this claim?
News 
Market Data 
Discover 
